94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
N. Claeys1M. T. Teeling1P. Legrand1M. Poppe1P. Verschueren1
L. De Prins2L. Cools2L. Cypers2*W. J. Fokkens3,4C. Hopkins3,5P. W. Hellings3,4,6,7- 1Patient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium
- 2Patient Liaison Officers of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium
- 3The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium
- 4Department of Otorhinolaryngology, Head & Neck Surgery, Academic Medical Center (AMC), Amsterdam, Netherlands
- 5Guy's and St Thomas' Hospital, London Bridge Hospital, London, United Kingdom
- 6Department of Otorhinolaryngology, Head and Neck Surgery, Universitair Ziekenhuis Leuven, Leuven, Belgium
- 7Department of Otorhinolaryngology, University of Ghent, Ghent, Belgium
A Corrigendum on
Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA
by Claeys, N., Teeling, M. T., Legrand, P., Poppe, M., Verschueren, P., De Prins, L., Cools, L., Cypers, L., Fokkens, W. J., Hopkins, C., and Hellings, P. W. (2021). Front. Allergy 2:761388. doi: 10.3389/falgy.2021.761388
In the original published article, there was an error in the Funding statement. The incorrect statement read “Funding was provided via an unrestricted grant to EUFOREA by Sanofi Genzyme.” The correct statement is “Funding was provided via an unrestricted grant to EUFOREA by Sanofi Genzyme and Regeneron.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: nasal polyps, oral corticosteroids, quality of life, unmet needs, chronic rhinosinusitis
Citation: Claeys N, Teeling MT, Legrand P, Poppe M, Verschueren P, De Prins L, Cools L, Cypers L, Fokkens WJ, Hopkins C and Hellings PW (2021) Corrigendum: Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA. Front. Allergy 2:789425. doi: 10.3389/falgy.2021.789425
Received: 04 October 2021; Accepted: 12 October 2021;
Published: 29 October 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Claeys, Teeling, Legrand, Poppe, Verschueren, De Prins, Cools, Cypers, Fokkens, Hopkins and Hellings. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: L. Cypers, bGluZHNheS5jeXBlcnNAZXVmb3JlYS5ldQ==